| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 16, 2024 | May 20, 2024 | Enliven Therapeutics, Inc. | Director | Sell | 15.0 | -1,033,300 | -11.54% | ✗ | $22.9M |
| May 11, 2023 | May 15, 2023 | Verona Pharma plc | Director | Sell | 16.3 | -482,913 | -11.33% | ✗ | $9.9M |
| Dec 22, 2022 | Dec 27, 2022 | Verona Pharma plc | Director | Sell | 15.0 | -6,139,864 | -15.26% | ✗ | $136M |